St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
Synovial sarcoma is a type of soft tissue sarcoma. It is a cancer that starts in the soft tissues near the joints. It sometimes occurs in the kidneys and lungs.
Synovial sarcoma has no known risk factors. But genetics may play a role in its growth.
Synovial sarcoma is rare. It is somewhat more common in males. About 800 new cases of synovial sarcoma are diagnosed in the United States each year.
Synovial sarcoma tumors often grow slowly. It may be a long time before they cause symptoms. They appear near the affected area, usually in the hands, lower leg, or feet.
Symptoms may include:
Several tests are used to diagnose synovial sarcoma. These include:
Surgery to remove the tumor is the main treatment.
Sometimes children need more treatment. This depends on the size of the tumor and how it looks under a microscope.
Other treatments may include:
The survival rates for people with synovial sarcoma have improved during the past 20 years because of advances in surgery, chemotherapy, and radiation therapy.
The factors that lead to better outcomes include:
The survival rate for synovial sarcoma ranges from 36–76%. But each person’s experience is unique. Results are hard to predict. The survival rate for synovial sarcoma is lower in cases where the cancer has returned or spread.
St. Jude provides the highest quality of care for patients with synovial sarcoma:
More reasons to choose St. Jude for care include:
St. Jude offers clinical trials and cancer research studies for children, teens, and young adults with synovial sarcoma. Learn more about clinical research at St. Jude.
Study goal:
The purpose of this clinical trial is to find better treatments for NRSTS patients who are intermediate- and high-risk. Our goal is to lower the risk of the tumor coming back after treatment, while using treatments with fewer risks of long-term side effects.
Age:
Up to 30 years old.
Patients accepted to St. Jude must have a disease we treat and must be referred by a physician or other qualified medical professional. We accept most patients based on their ability to enroll in an open clinical trial.
Call: 1-888-226-4343 (toll-free) or 901-595-4055 (local) | Fax: 901-595-4011 | Email: referralinfo@stjude.org | 24-hour pager: 1-800-349-4334
The solid tumor coordinator is dedicated to helping you seek treatment or refer a patient.
Solid Tumor Coordinator